関連する実験動画
Updated: Jan 6, 2026
01:19
Mitral Valve Prolapse III: Nursing Management
Published on: June 19, 2025
252
酸化ストレスは,腫瘍死滅因子アルファ誘発のミトコンドリアDNA損傷と心筋細胞の機能障害を媒介する
Nobuhiro Suematsu1, Hiroyuki Tsutsui, Jing Wen
1Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Circulation
|March 19, 2003
まとめ
腫瘍死滅因子アルファ (TNF-alpha) は,心細胞の活性酸素種 (ROS) 生成とミトコンドリアDNA (mtDNA) 損傷を誘発し,心不全を引き起こす. アンジオテンシンII (Ang II) はROSを増加させますが,mtDNAを損傷しません.
科学分野:
- 心臓病学 心臓病学
- 分子生物学は分子生物学である.
- バイオケミストリー バイオケミストリー
背景:
- 腫瘍死滅因子アルファ (TNF-alpha) とアンジオテンシンII (Ang II) は,潜在的に活性酸素種 (ROS) 経由で,心不全の進行と関連しています.
- アゴニスト誘発のROS生成の正確なメカニズムと,心筋細胞,特にミトコンドリアDNA (mtDNA) に与える影響は不明である.
- 以前の研究では,ROSの上昇,mtDNAの損傷,心不全における機能障害との関連が示されました.
研究 の 目的:
- TNF-αとAng IIに心臓のミオサイトを直接暴露すると,ROSの生成によってmtDNAの損傷が誘発されるかどうかを調べる.
- TNF-α媒介のROS生成およびその後のmtDNA損傷に関与するシグナル伝達経路を解明する.
主な方法:
- 培養された新生児ラットの室内ミオサイトは,TNF-alphaとAng IIにさらされた.
- 反応性酸素種 (ROS) の生成は,2',7'-ジクロルオフローレシン二酸化酸塩の光を用いて評価された.
- ミトコンドリアDNA (mtDNA) のコピー番号は,サザンブロット分析によって定量化されました.
- スフィンゴミエリン-セラミド経路の役割は,D609とC2-セラミドを用いて調べられた.
主要な成果:
- TNF-αは,ROSの産生を著しく増加させ,ミオサイトにおけるmtDNA複製数を減少させた.
- TNF-α誘発によるmtDNA複製数の減少は,複合体IIIの活性低下と関連しており,アルファトコフェロールによって予防された.
- 水素過酸化物 (H2O2) 曝露はmtDNA複製数の減少を模倣した.
- Ang IIはROSを増加させましたが,mtDNA複製数には影響しませんでした.
- スフィンゴミエリンゼ阻害剤D609とC2-セラミドは,TNF-α媒介のROS生成とmtDNA損傷を阻害し,スフィンゴミエリン-セラミド経路を関与させた.
結論:
- TNF-αは,スフィンゴミエリン-セラミド経路経由で心筋細胞のROS生成とmtDNA損傷を誘導する.
- TNF-α,ROS,mtDNAの損傷の間のこのリンクは,心筋の再編成と心不全の潜在的な寄与者です.
- 同様のROS誘導にもかかわらず,mtDNA損傷におけるアニオテンシンIIの役割は,TNF-αと異なるように見える.
関連する概念動画
Mitral Valve Prolapse III: Nursing Management
252
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
252
Cancer Vaccines
917
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
917
Development of Immunocompetence
759
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
759
Vaccinations
51.1K
Overview
51.1K
Healthcare Associated Infections II: Preventive Measures
3.5K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.5K
Teratogenicity
3.9K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.9K